Metprocer

In Newly Diagnosed Hypertensive Patients

Metoprolol Succinate 25 mg / 50 mg Extended Release Tablets

The Selective Beta Blocker for Long Term Benefits

  • Improvement in left ventricular ejection fraction
  • Competitive antagonism at peripheral leading to decreased cardiac output, Heart Rate & BP
  • Central effect leading to reduced sympathetic outflow and suppression of renin activity

In Essential Hypertension & Coronary Heart Disease

Metoprolol Succinate (ER) 50 mg + Amlodipine 5 mg Tablets

Predictable Efficacy with Enhanced Cardioprotection

  • 39% Risk reduction in cardiac and nonfatal acute MI
  • 71% patients achieved normalized BP in 8 weeks

Want to know more about our Products
Call Us: +91 9986662266